David Rasnick PhD.
Chief Science Officer, Boveran Inc., Saratoga, CA. PhD in chemistry from Georgia Tech 1978, 25 years experience with proteases
and protease inhibitors, worked 20 years in pharmaceutical industry
developing protease inhibitors for tissue destroying diseases: cancer,
emphysema, arthritis, parasitic diseases; studied AIDS 19 years; former
President of Rethinking AIDS: the group for the scientific reappraisal of
the HIV hypothesis; former president of International Coalition for Medical
Justice; advisor to South African President Thabo Mbeki and a member of his
expert AIDS panel, which met in Pretoria and Johannesburg, South Africa, May
and July 2000. Most recent scientific publication in the area of AIDS is:
"The AIDS Dilemma: Drug Diseases Blamed on a Passenger Virus," P. H.
Duesberg and D. Rasnick, Genetica 104, 85-132 (1998).